Business Wire

Axonics Announces First Fecal Incontinence Patients Implanted with Its Miniaturized Rechargeable Sacral Neuromodulation System

IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc., the developer of the first rechargeable Sacral Neuromodulation (r-SNM™) System for the treatment of urinary and fecal ...
FierceBiotech

Axonics kicks off U.S. launch of recharge-free sacral neuromodulation implant

Barely a month after winning FDA clearance for its long-lasting implant to treat bladder dysfunction, Axonics is wasting no time in bringing the device to the masses. The Southern California-based ...
Business Wire

Axonics Granted Four U.S. Patents Related to its Implantable Sacral Neuromodulation Technology

IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc., developer of the first rechargeable Sacral Neuromodulation (r-SNM™) system for the treatment of urinary and fecal dysfunction, ...
FierceBiotech

On Medtronic's tail, Axonics scores FDA nod for 15-year neurostim implant for incontinence

The race to treat a number of health conditions using neurostimulation technology is a marathon, not a sprint—but Medtronic and Axonics Modulation Technologies are still aiming for a photo finish. For ...
CNBC

Medical device maker Boston Scientific to buy Axonics for $3.7 billion

Medical device maker Boston Scientific said on Monday it had agreed to buy Axonics for $3.7 billion, gaining access to devices used to improve bladder function. The deal marks Boston Scientific's ...